ArticleBMC cancer2022

The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer.

Pratibha S Binder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.